These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1639876)
21. The roles of cell Ca2+, protein kinase C and the Na(+)-H+ antiport in the development of hypertension and insulin resistance. Aviv A J Am Soc Nephrol; 1992 Nov; 3(5):1049-63. PubMed ID: 1336404 [TBL] [Abstract][Full Text] [Related]
22. Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM. Taskinen MR Adv Exp Med Biol; 1993; 334():295-301. PubMed ID: 8249693 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of hypertension associated with diabetes mellitus]. Katayama S Nihon Rinsho; 1997 Aug; 55(8):2091-6. PubMed ID: 9284429 [TBL] [Abstract][Full Text] [Related]
24. New paradigms in neuroendocrinology: relationships between obesity, systemic inflammation and the neuroendocrine system. Toni R; Malaguti A; Castorina S; Roti E; Lechan RM J Endocrinol Invest; 2004 Feb; 27(2):182-6. PubMed ID: 15129816 [TBL] [Abstract][Full Text] [Related]
25. Coronary artery disease: a link between hypertension, diabetes mellitus, hyperlipidemia, and obesity. Amanti M; Schumann L J Am Acad Nurse Pract; 1998 Feb; 10(2):77-81; quiz 82-4. PubMed ID: 9616571 [No Abstract] [Full Text] [Related]
26. Diabetic dyslipidemia. Kreisberg RA Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665 [TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and antidiabetic drugs. Bailey CJ Biochem Pharmacol; 1999 Nov; 58(10):1511-20. PubMed ID: 10535741 [TBL] [Abstract][Full Text] [Related]
28. [Childhood obesity increases the risk of coronary artery disease]. Nuutinen O; Nuutinen M Duodecim; 2001; 117(13):1356-62. PubMed ID: 12184126 [No Abstract] [Full Text] [Related]
29. [Risk factors for atherosclerosis in non-insulin-dependent diabetes]. Van Gaal LF; de Leeuw IH Journ Annu Diabetol Hotel Dieu; 1992; ():101-12. PubMed ID: 1495229 [No Abstract] [Full Text] [Related]
30. Hypertension as a metabolic disorder--an overview. Smith U; Gudbjörnsdottir S; Landin K J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218 [TBL] [Abstract][Full Text] [Related]
31. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects]. Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857 [TBL] [Abstract][Full Text] [Related]
32. The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis. Bain SC; Dodson PM Postgrad Med J; 1991 Oct; 67(792):922-7. PubMed ID: 1758805 [No Abstract] [Full Text] [Related]
34. Type II diabetes and syndrome X. Pathogenesis and glycemic management. Karam JH Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069 [TBL] [Abstract][Full Text] [Related]
39. [Coronary risk factors. Anatomoclinical study]. Degeratu T; Nicolaescu V; Nuţă M; Cîmpeanu A; Cucu N Med Interna (Bucur); 1974 Jan; 26(1):61-72. PubMed ID: 4821152 [No Abstract] [Full Text] [Related]
40. The coronary artery disease paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy. Black HR J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S26-38. PubMed ID: 1694928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]